Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
aggression
algorithm
amnestic syndrome
AMPA receptor antibodies
AMPA receptors
amygdala
anti GQ1b IgG antibody
ataxia
ataxia, cerebellar
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
autonomic dysfunction
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavior, combative
behavioral disorder
behavioral disorder, acute
carcinoma
carcinoma of lung
CAT scan, chest
catatonia
cerebellum
cerebral cortex
children
chorea
choreoathetosis
collapsin response mediator protein 5 IgG
complications
confusion
contactin associated protein like 2 antibodies
dementia
dementia, reversible
diagnostic criteria
diarrhea
differential diagnosis
DPPX, antibodies, encephalitis
dyskinesia
dyskinesia, facial
dystonia
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
encephalopathy, Hashimoto's
faciobrachial dystonic seizure
false negative
fever
gamma amino butyric acid receptor antibody
gammaglobulin therapy, intravenous
gender
GluD2
glutamic acid decarboxylase, antibody
glycine receptor antibodies
hallucination
hallucination, visual
headache
herpes simplex encephalitis
hippocampus
hippocampus, hyperintense
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
hyperekplexia
hypersomnia
hyponatremia
immunologic disease
immunosuppressive agents
immunotherapy
inappropriate antidiuretic(A.D.H.)hormone
insomnia
insular cortex
intellectual deficit
intellectual deterioration
Jakob-Creutzfeldt disease
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
limbic encephalitis
limbic system
malignancy screen
mediastinum, mass of
memory, defect of recent
memory, impairment of
mental status, abnormal
mesial temporal lobe
mimics
misdiagnosis
monoclonal antibodies
Morvan's fibrillary chorea
movement disorder
MRI
MRI, abnormal
MRI, false negative
MRI, FLAIR
MRI, negative
myelitis, transverse, recurrent
myoclonus
negative
neurexin-3 alpha antibodies
neurologic complications of, systemic cancer
neurologic disease, diagnoses of
neuronal cell surface antigen
NMDA antagonists
ophelia syndrome
opsoclonus
opsoclonus-myoclonus syndrome
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
personality change
pleocytosis of cerebrospinal fluid
potassium channel antibodies
practice guidelines
precipitating factors
prognosis
psychiatric problems in neurologic disorders
psychosis
Purkinje cell
Purkinje cell surface antibody
recurrent
remote effect of cancer on the nervous system
reversible neurologic disorder
review article
rituximab
screening
seizure
serologic testing
serologic testing, false negative
seronegative
sleep pathology and physiology
steroid
steroid responsive encephalopathy
steroid therapy, CNS treatment and complications with
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
symmetric brain lesions
syphilis, neurologic complications with
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
thymoma
treatment of neurologic disorder
tremor
violent behavior
weight loss
white matter disease
white matter disease, subcortical
workup
Showing articles 700 to 750 of 772 << Previous Next >>

Reduction in Size of Prolactin-secreting Tumours in Men Treated with Pergolide
BMJ 285:465-467, Kendall-Taylor,P.,et al, 1982

Bromocriptine-induced psychosis in acromegaly
BMJ 285:1315, Lefeuvre,C.M.,et al, 1982

Bromocriptine:Low-dose Therapy in Parkinson Disease
Neurol 32:577-583, Teychenne,P.F.,et al, 1982

Pergolide Mesylate & Idiopathic Parkinson Disease
Neurol 32:1175-1179, Tanner,C.M.,et al, 1982

Pergolide in Late-Stage Parkinson Disease
Ann Neurol 12:243-247, Lang,A.E.,et al, 1982

Further Studies with Pergolide in Parkinson Disease
Neurol 32:1181-1184, Lieberman,A.N.,et al, 1982

Bromocriptine Reduces Pituitary Tumor Size & Hyper-secretion
JAMA 247:311-316, Spark,R.F.,et al, 1982

CSF Rhinorrhea After Bromocriptine For Prolactinoma
NEJM 306:178, Baskin,D.S.,et al, 1982

Prolactinoma:A Question of Rational Treatment
BMJ 283:1561-1562, Edwards,C.R.W.,et al, 1981

Bromocriptine Therapy for"Nonfunctioning"Pituitary Tumors
Am J Med 71:1059-1061, Johnston,D.G.,et al, 1981

Bromocriptine In Acromegaly
NEJM 305:1092-1093, Thorner,M.O.,et al, 1981

Effect Of Bromocriptine On Brain Metastasis In Breast Cancer
Lancet 2:745-746, Grisoli,F.,et al, 1981

Lisuride in Parkinson Disease:Efficacy of Lisuride Compared to Levodopa
Neurol 31:961-965, Lieberman,A.N.,et al, 1981

Cimetidine Toxic Reactions Masquerading as Delirium Tremens
JAMA 245:1058-1059, Weddington,W.W.,et al, 1981

Cimetidine Interaction with Phenytoin
BMJ 282:1512, Hetzel,D.J.,et al, 1981

No Direct Correl. of Serum Ach Receptor Antib. Levels & Clin. State of Individual Patients with Myasthenia Gravis
Neurol 31:220-224, Roses,A.D.,et al, 1981

No Effect Of Bromocriptine In Acromegaly
NEJM 304:1450-1454, Lindholm,J.,et al, 1981

Regression of Pituitary Prolactinoma With Bromocriptine Administration
JAMA 245:1149-1150, Velentzas,C.,et al, 1981

Mental Disorders From Low-Dose Bromocriptine
NEJM 305:173, Pearson,K.D., 1981

Bromocriptine & Domperidone in the Treatment of Parkinson Disease
Neurol 31:662-667, Quinn,N.,et al, 1981

Lisuride in Parkinsonism
Neurol 31:371-376, Gopinathan,G.,et al, 1981

Treatment of Advanced Parkinson Disease With Pergolide
Neurol 31:675-682, Lieberman,A.,et al, 1981

Extrapyramidal Side-Effects Of Metoclopramide
Lancet 2:1254-1255, Kataria,M.,et al, 1981

Parkinsonism & Tardive Dyskinesia Associated With Long-Term Metoclopramide Therapy
NEJM 305:1417, Grimes,J.D., 1981

Akinetic Mutism from Hypothalamic Damage:Successful Treatment with Dopamine Agonists
Neurol 31:1435-1439, Ross,E.D.,et al, 1981

Delayed Clearance of Diazepam Due to Cimetidine
NEJM 302:1012-1014, Klotz,U.,et al, 1980

Humoral Immunity in Myasthenia Gravis:Effect of Steroids & Thymectomy
Neurol 30:554-557, Tindall,R.S.A., 1980

Alcohol Increases Bromocriptine's Side Effects
NEJM 302:806, Ayres,J.,et al, 1980

Motor Neuropathy Associated with Cimetidine
BMJ 281:974-975, Walls,T.J.,et al, 1980

Ultrastructural Localization of Ach Receptor at the Motor Endplate:MG & Other Neuromuscular Dis
Neurol 30:1203-1211, Tsujihata,M.,et al, 1980

Increased Hair Loss As A Side Effect of Bromocriptine Treatment
NEJM 303:1418, Blum,I.,et al, 1980

Reduction in Size of a Pituitary Tumor by Bromocriptine Therapy
NEJM 300:291-293, McGregor,A.M.,et al, 1979

The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979

Bromocriptine in Parkinson Disease:Further Studies
Neurol 29:363-369, Lieberman,A.N.,et al, 1979

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Neonatal Myasthenia Gravis in the Infant of a Myasthenic Mother in Remission
Ann Neurol 6:72-75, Elias,S.B.,et al, 1979

Effect of Bromocriptine on Pituitary Tumor Size
BMJ 2:700-703, McGregor,A.M.,et al, 1979

Bromocriptine Fails To Stop Growth of Eosinophilic Adenoma In Acromegaly
NEJM 301:386, Salti,I.S., 1979

Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979

The Role of Bromocriptine in the Treatment of Parkinsonism
Neurol 29:1077-1083, Fahn,S.,et al, 1979

Serum Antibodies to Cytomegalovirus in Myasthenia Gravis:Effects of Thymectomy & Steroids
Neurol 28:273, Tindall,R.S.A.,et al, 1978

Function of Circulating Antibody to Acetylcholine Receptor in Myasthenia Gravis:Investigation by Plasma Exchange
Neurol 28:266, Newsom-Davis,J.,et al, 1978

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Comparison Between Lergotrile & Bromocriptine in Parkinsonism
Ann Neurol 3:319, Teychenne,P.F.,et al, 1978

Bromocriptine in Parkinsonism
Arch Neurol 35:503, Lees,A.J.,et al, 1978

Lergotrile in the Treatment of Parkinsonism
Neurol 28:699, Klawans,H.L.,et al, 1978

Content of Acetylch Receptor & Antib Bound to Receptor in Myasth Gravis, Experi Autoimm Myasth Gravis, & Syndrome
Neurol 28:130, Lindstrom,J.M., 1978

Acetylcholine Receptor in Myasthenia Gravis:Increased Affinity for a-Bungarotoxin
Ann Neurol 4:250-252, Elias,S.B.,et al, 1978

Penicillamine-induced Myasthenia Gravis Associated with Antibodies to Acetylcholine Receptor
Neurol 28:847-849, Russell,A.S.,et al, 1978

Prolactin-Secreting Tumors & Hypogonadism in 22 Men
NEJM 299:847-852, Carter,J.N.,et al, 1978



Showing articles 700 to 750 of 772 << Previous Next >>